Top 20 Companies in the Global Pet Noise Anxiety Drugs Market (2026–2035): Expert View by Spherical Insights
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Pet Noise Anxiety Drugs Market Size Is Projected To Grow From USD 1.573.2 Million In 2025 To USD 3, 043.7 Million By 2035, At A CAGR Of 6.6% During The Forecast Period 2026–2035. Global market expansion is fuelled by the growing prevalence of noise-related anxiety in pets, surging pet ownership, rising awareness of animal mental health, and the availability of advanced pharmacological treatments to manage stress and behavioural disorders.
Introduction
The Global Pet Noise Anxiety Drugs Market experiences growth because of the urbanisation and louder environments, together with fireworks and thunderstorms, create more common stressors, which lead to increased noise-related anxiety disorders in dogs and cats. The anthropomorphism of pets has led to greater pet ownership in developed and developing countries. Pet owners understand their pets require emotional support, so they dedicate their resources to veterinary treatments, which increases demand for anxiety management solutions. The veterinary pharmaceutical advancements, together with the veterinary service expansion and diagnostic tool development, have created more treatment options for patients. The innovation will lead veterinarians, together with pet owners, to choose professional solutions that enhance animal welfare.
For instance, the most common pet behaviour disorder affects 25% to 50% of dogs worldwide, according to scientific and veterinary studies, which demonstrate that dogs experience noise-related anxiety or phobia.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Pet Noise Anxiety Drugs Market Size & Statistics
- The Market Size for Pet Noise Anxiety Drugs Was Estimated to be worth USD 1.573.2 Million in 2025.
- The Market Size is Going to Expand at a CAGR of 6.6% between 2026 and 2035.
- The Global Pet Noise Anxiety Drugs Market Size is anticipated to reach USD 3, 043.7 Million by 2035.
- North America is estimated to dominate the market during the forecast period in the Pet Noise Anxiety Drugs Market.
- Asia-Pacific is projected to grow the fastest during the forecast period in the Pet Noise Anxiety Drugs Market.
Market Segmentation
Global Pet Noise Anxiety Drugs Market Size, Share, By Species (Canine, Feline, and Equine), By Drug Molecule (Fluoxetine, Clomipramine, Gabapentin, Alprazolam, Buspirone, Cannabidiol, and Others), By Formulation (Oral Medication, Tropical, and Injectable Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 – 2035.
Regional growth and demand
North America is expected to dominate the market during the forecast period in the pet noise anxiety drugs market
North America held the majority of the market share by revenue for the pet noise anxiety drugs market. The region is fuelled by the high prevalence of pets in households, awareness regarding pet psychological well-being, and robust veterinary facilities. The region enjoys state-of-the-art veterinary medical services, reliable channels for distribution of pharmaceutical drugs, and increasing acceptance of pets as members of the family.
Asia Pacific is projected to grow the fastest during the forecast period in the pet noise anxiety drugs market
Asia Pacific is expected to grow the fastest during the forecast period in the pet noise anxiety drugs market. This is attributed to the rising adoption rates of pets, higher disposable incomes, and an increased awareness of the health and welfare of animals in countries such as China, India, and Japan. The growing number of veterinary clinics, new drugs to treat anxiety in animals, and better availability of over-the-counter and prescription medicine for pets are contributing factors towards increasing pet adoption, as are behavioural problems in stressed-out animals.
For instance, Veterinarians observed higher sales of pet soothing medications during periods of increased public demand, which occurred during Diwali festivals and fireworks shows, according to news reports.
Ready to lead the Pet Noise Anxiety Drugs Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Pet Noise Anxiety Drugs Market
- Increasing demand for prescription-based anxiety medications
- Growing popularity of natural and alternative (CBD & herbal) solutions
- Rising adoption of wearable calming products and smart devices
- Integration of technology in pet anxiety monitoring and treatment
- Expansion of e-commerce and direct-to-consumer distribution channels
- Shift toward combination therapies (behavioural + pharmacological)
- Development of fast-acting and targeted veterinary drugs
- Increasing focus on pet mental health and preventive care
- Rising use of sound therapy and environmental modification solutions
- Growth in veterinary recommendations and clinically backed treatments
1.Increasing demand for prescription-based anxiety medications
More and more pet owners are resorting to drugs prescribed by veterinarians for dealing with severe cases of pet noise anxiety. The advantages of these drugs include clinically proven efficiency and the ability to use them for both chronic and acute states of anxiety. The increased level of trust in the advice of veterinarians contributes to the increased popularity of these products.
2.Growing popularity of natural and alternative (CBD & herbal) solutions
The use of various natural products as an alternative treatment is becoming more popular. This includes CBD oils, herbal remedies, and pheromones that help deal with anxiety without side effects. This approach reflects the current tendency toward holistic pet care and treatment.
3.Growing popularity of natural and alternative (CBD & herbal) solutions
Innovative products such as vests, anxiety collars, and smart trackers that are designed to relieve pets from stress are becoming popular. These products help alleviate anxiety due to pressure therapy or the monitoring of behaviour.
4.Integration of technology in pet anxiety monitoring and treatment
The emergence of technology is facilitating better management of anxiety symptoms among pets through improved monitoring of treatments by pet owners and veterinarians. This will contribute to the success of the treatment as well as enhance the overall well-being of the pets.
5.Expansion of e-commerce and direct-to-consumer distribution channels
The Internet has made these medicines and supplements more readily available for pets that suffer from anxiety disorders. The consumer receives many advantages, including the availability of products, a wide variety of products, and the ability to read reviews and get expert advice from veterinarians.
Empower your strategic planning
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the anti-venom market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Pet Noise Anxiety Drugs Market
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Ceva Sante Animale
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Bayer AG
- Nutramax Laboratories, Inc.
- Thorne Veterinary
- Zesty Paws, LLC
- PetHonesty
- Nestle Purina PetCare
- ThunderWorks
- Pet Acoustics, Inc.
- PetMed Express, Inc.
- The Hartz Mountain Corporation
- PetIQ, LLC
- Mars Petcare Inc.
1. Zoetis Inc.
Headquarters: Parsippany, New Jersey, USA
Zoetis Inc. entered the business arena in the year 1952 and separated itself from Pfizer in 2013, whereas the company made sales of 9.3 billion dollars during 2024, becoming the largest supplier of animal health products. The company provides a product range comprising vaccines, anti-infectives, and parasiticides, as well as dermatology and pain medicines, which comprise Apoquel and Cytopoint, as well as other medicines to treat pet anxiety and stress. The company conducts its business operations in more than 100 countries since its research efforts and medical solutions for companion animals allow it to take control of the North American, European, and emerging markets.
2. Elanco Animal Health Incorporated
Headquarters: Indianapolis, Indiana, USA
Elanco Animal Health Incorporated was established in the year 1954 as a division of Eli Lilly and Company but was spun off in the year 2017 and became an independent company. The company provides several products related to pets' health conditions, which include parasiticides, dermatology medicines, and other medicines managing pets' behaviour and anxiety problems. The company's operations cover more than 90 countries around the world, and by acquiring Bayer Animal Health, the business operations of the company have been strengthened. The company shows a strong commitment to innovation.
3. Boehringer Ingelheim
Headquarters: Ingelheim am Rhein, Germany
Boehringer Ingelheim Animal Health, which started its operations in 1885, now stands as one of the leading private animal health companies that generates between 5 and 6 billion US dollars in revenue from its animal health business during the 2024 financial year. The company provides multiple products that include vaccines and antiparasitic and therapeutic medicines, which help companion animals by solving their behavioural problems and stress issues. Boehringer Ingelheim has built a strong international presence across its European, American and Asia-Pacific business operations, while its Merial acquisition enabled substantial expansion of its animal health business.
4. Merck Animal Health
Headquarters: Madison, New Jersey, USA
Merck Animal Health has been a subsidiary of Merck & Co., Inc. since its inception in 1891 and recorded about USD 5.6 billion in animal health revenues in 2024, having a wide portfolio of vaccines, pharmaceuticals, and monitoring systems for pets and livestock. This organisation provides its customers with various pet services to ensure that the pets have good health and behaviour despite stressful conditions. It is operating in more than 50 countries worldwide and is known for its innovative approach in animal healthcare solutions using technological innovations like livestock and pet monitoring systems.
5. Ceva Sante Animale
Headquarters: Libourne, France
Established in 1999 with headquarters in France, Ceva Sante Animale, which generates annual revenues between $1.5 billion and $2 billion, focuses on developing veterinary pharmaceutical products and vaccines. Ceva produces behavioural medicines that use pheromones to help pets overcome stress caused by loud sounds through its product Adaptil. The company operates in more than 110 countries, but its primary distinction comes from its ability to help pets relieve stress.
Are you ready to discover more about the Pet Noise Anxiety Drugs Market?
The report provides an in-depth analysis of the leading companies operating in the global pet noise anxiety drugs market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardised format that includes:
Company Profile
- Zoetis Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Ceva Sante Animale
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Bayer AG
- Nutramax Laboratories, Inc.
- Thorne Veterinary
- Zesty Paws, LLC
- PetHonesty
- Nestle Purina PetCare
- ThunderWorks
- Pet Acoustics, Inc.
- PetMed Express, Inc.
- The Hartz Mountain Corporation
- PetIQ, LLC
- Mars Petcare Inc.
Conclusion
Global market expansion is fuelled by the growing prevalence of noise-related anxiety in pets, surging pet ownership, rising awareness of animal mental health, and the availability of advanced pharmacological treatments to manage stress and behavioural disorders. North America is expected to dominate the market during the forecast period due to the high prevalence of pets in households, awareness regarding pet psychological well-being, and robust veterinary facilities. Asia Pacific is projected to grow the fastest during the forecast period due to rising adoption rates of pets, higher disposable incomes, and an increased awareness of the health and welfare of animals.
Our Reports:t
B2C Live Streaming Video Platform Market Trends, Growth, Forecast Report 2035
Bakery Ingredients Market Size, Share, Forecast To 2035
Barware Market Size, Share,Forecast
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?